Cargando…

Uptake and Utilization of the Management of Anticoagulation in the Periprocedural Period App: Longitudinal Analysis

BACKGROUND: Anticoagulants are major contributors to preventable adverse drug events, and their optimal management in the periprocedural period is particularly challenging. Traditional methods of disseminating clinical guidelines and tools cannot keep pace with the rapid expansion of available thera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spyropoulos, Alex C, Myrka, Anne, Triller, Darren M, Ragan, Stephen, York, Collin, King, Jaz-Michael, Lee, Ti-Kuang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JMIR Publications 2018
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320435/ https://www.ncbi.nlm.nih.gov/pubmed/30578235 http://dx.doi.org/10.2196/11090

Ejemplares similares

Implementation of the Management of Anticoagulation in the Periprocedural Period App into an Electronic Health Record: A Cost-Effectiveness Analysis
por: Wang, Jason J., et al.
Publicado: (2023)

Implementation of the Management of Anticoagulation in the Periprocedural Period App Into an Electronic Health Record: A Prospective Cohort Study
por: Spyropoulos, Alex C., et al.
Publicado: (2020)

Periprocedural anticoagulation in atrial fibrillation: Update on electrical cardioversion and ablation
por: van Vugt, S. P. G., et al.
Publicado: (2018)

Periprocedural anticoagulation in transcatheter aortic valve replacement: Heparin vs bivalirudin
por: Minhas, Abdul Mannan Khan, et al.
Publicado: (2017)

Outcomes in patients undergoing periprocedural interruption of warfarin or direct oral anticoagulants
por: Lee, Jeffrey, et al.
Publicado: (2022)

Periprocedural Management of Direct Oral Anticoagulants Should Be Guided by Accurate Laboratory Tests
por: Lessire, Sarah, et al.
Publicado: (2016)

Periprocedural Management of Direct Oral Anticoagulants Surrounding Cardioversion and Invasive Electrophysiological Procedures
por: Finks, Shannon W., et al.
Publicado: (2018)

Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation
por: Maraj, Ilir, et al.
Publicado: (2018)

Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants
por: Brinkmeier-Theofanopoulou, Maria, et al.
Publicado: (2018)

Periprocedural anticoagulation in non-ST-segment elevation acute coronary syndrome: time to reassess?
por: Chandiramani, Rishi, et al.
Publicado: (2020)

Thromboembolic and bleeding risk of periprocedural bridging anticoagulation: A systematic review and meta‐analysis
por: Kuo, Hsien‐Cheng, et al.
Publicado: (2020)

Hyphema: A Rare Complication of Periprocedural Antiplatelets and Anticoagulants Following Percutaneous Coronary Intervention
por: Gulati, Amit, et al.
Publicado: (2021)

Comparison of uninterrupted anticoagulation with dabigatran etexilate or warfarin in the periprocedural period for atrial fibrillation catheter ablation: Results of the Japanese subgroup of the RE‐CIRCUIT trial
por: Yoshida, Yukihiko, et al.
Publicado: (2018)

Periprocedural heparin bridging in patients receiving oral anticoagulation: a systematic review and meta-analysis
por: Yong, Jing Wen, et al.
Publicado: (2017)

Periprocedural Direct Oral Anticoagulant Management: The RA-ACOD Prospective, Multicenter Real-World Registry
por: Ferrandis, Raquel, et al.
Publicado: (2020)

Considerations Regarding the Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation
por: Reiffel, James A.
Publicado: (2018)

Periprocedural use of avatrombopag for neurosurgical interventions: a strategy to avoid platelet utilization
por: Lim, Ming Y., et al.
Publicado: (2020)

Outcomes of uninterrupted vs interrupted Periprocedural direct oral Anticoagulants in atrial Fibrillation ablation: A meta‐analysis
por: Basu‐Ray, Indranill, et al.
Publicado: (2021)

Optimal Anticoagulant Strategy for Periprocedural Management of Atrial Fibrillation Ablation: A Systematic Review and Network Meta-Analysis
por: Kino, Tabito, et al.
Publicado: (2022)

Periprocedural anticoagulation in the uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation (ELIMINATE-AF) trial
por: Hohnloser, Stefan H, et al.
Publicado: (2020)

Brief History of Opioids in Perioperative and Periprocedural Medicine to Inform the Future
por: Boysen, Philip G., et al.
Publicado: (2023)

Factors associated with periprocedural myocardial infarction
por: Okşul, Metin, et al.
Publicado: (2019)

Periprocedural myocardial injury in the EXCEL trial
por: Bjørnstad, Johannes L, et al.
Publicado: (2020)

Report of periprocedural oral anticoagulants in catheter ablation for atrial fibrillation: The Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF)
por: Murakawa, Yuji, et al.
Publicado: (2017)

A Mobile Web App to Improve Health Screening Uptake in Men (ScreenMen): Utility and Usability Evaluation Study
por: Teo, Chin Hai, et al.
Publicado: (2019)

Advances in Analgosedation and Periprocedural Care for Gastrointestinal Endoscopy
por: Skiljic, Sonja, et al.
Publicado: (2023)

Impact of frailty on periprocedural health care utilization in patients undergoing transcatheter edge-to-edge mitral valve repair
por: Iliadis, Christos, et al.
Publicado: (2020)

Exploring Users’ Experiences of the Uptake and Adoption of Physical Activity Apps: Longitudinal Qualitative Study
por: Baretta, Dario, et al.
Publicado: (2019)

Periprocedural considerations of transcatheter aortic valve implantation for anesthesiologists
por: Afshar, Ata Hassani, et al.
Publicado: (2016)

The relevance of periprocedural troponin rise: the never ending story!
por: Fröhlich, Georg Marcus, et al.
Publicado: (2017)

Patient periprocedural stress in cardiovascular medicine: friend or foe?
por: Iwaszczuk, Paweł, et al.
Publicado: (2021)

Gastrostomy tubes: Fundamentals, periprocedural considerations, and best practices
por: Rajan, Anand, et al.
Publicado: (2022)

Class III Antiarrhythmics and Periprocedural Torsades de Pointes
por: Font, Cristina M., et al.
Publicado: (2023)

Healthcare Resource Utilization for Oral Anticoagulant Reversal Therapies in Non-Valvular Atrial Fibrillation/Venous Thromboembolism Patients
por: Spyropoulos, Alex C., et al.
Publicado: (2022)

Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO‐3 randomized trial
por: Zilberszac, Robert, et al.
Publicado: (2019)

Defining Minimum Necessary Communication During Care Transitions for Patients on Antihyperglycemic Medication: Consensus of the Care Transitions Task Force of the IPRO Hypoglycemia Coalition
por: Munshi, Medha N., et al.
Publicado: (2022)

Costs and Healthcare Resource Utilization Associated with Idarucizumab or Andexanet Alfa Oral Anticoagulant Reversal in Patients Hospitalized with Life-Threatening Bleeds
por: Spyropoulos, Alex C., et al.
Publicado: (2022)

Periprocedural Considerations During Implantation of ICD In A Patient With Dextrocardia
por: Aliyev, Farid, et al.
Publicado: (2010)

Impact of periprocedural myocardial necrosis on short term clinical outcome
por: Hamdi, M, et al.
Publicado: (2015)

Assessing the periprocedural magnitude of platelet count change in response to lusutrombopag
por: Brown, Robert S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e61m51olvssi7jnvr85tb5d5u9